nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—ADRB3—brown adipose tissue—adrenal gland cancer	0.155	0.488	CbGeAlD
Droxidopa—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.0622	0.196	CbGeAlD
Droxidopa—DDC—adrenal gland—adrenal gland cancer	0.0137	0.0431	CbGeAlD
Droxidopa—SLC16A10—gonad—adrenal gland cancer	0.0108	0.0339	CbGeAlD
Droxidopa—ADRB1—cardiac atrium—adrenal gland cancer	0.00878	0.0277	CbGeAlD
Droxidopa—ADRA2C—adrenal cortex—adrenal gland cancer	0.008	0.0252	CbGeAlD
Droxidopa—SLC6A2—gonad—adrenal gland cancer	0.00748	0.0236	CbGeAlD
Droxidopa—Aminosalicylic Acid—PTGS2—adrenal gland cancer	0.00705	0.56	CrCbGaD
Droxidopa—ADRA2C—cardiac atrium—adrenal gland cancer	0.00662	0.0208	CbGeAlD
Droxidopa—SLC6A2—adrenal gland—adrenal gland cancer	0.00652	0.0205	CbGeAlD
Droxidopa—ADRA2C—pituitary gland—adrenal gland cancer	0.00646	0.0204	CbGeAlD
Droxidopa—ADRA1A—adrenal gland—adrenal gland cancer	0.00606	0.0191	CbGeAlD
Droxidopa—ADRA2C—adrenal gland—adrenal gland cancer	0.00577	0.0182	CbGeAlD
Droxidopa—Mesalazine—PTGS2—adrenal gland cancer	0.00553	0.44	CrCbGaD
Droxidopa—ADRA2A—gonad—adrenal gland cancer	0.00529	0.0167	CbGeAlD
Droxidopa—ADRA2A—cardiac atrium—adrenal gland cancer	0.00528	0.0166	CbGeAlD
Droxidopa—ADRA2A—pituitary gland—adrenal gland cancer	0.00516	0.0162	CbGeAlD
Droxidopa—ADRA2A—adrenal gland—adrenal gland cancer	0.00461	0.0145	CbGeAlD
Droxidopa—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000563	0.000841	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000561	0.000837	CbGpPWpGaD
Droxidopa—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000549	0.00082	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000548	0.000818	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	0.00054	0.000806	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000533	0.000796	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00053	0.000791	CbGpPWpGaD
Droxidopa—PAH—Disease—CTNNB1—adrenal gland cancer	0.000526	0.000785	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000524	0.000782	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	0.000521	0.000777	CbGpPWpGaD
Droxidopa—ADRB1—GPCR ligand binding—POMC—adrenal gland cancer	0.000517	0.000772	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	0.000516	0.00077	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR ligand binding—POMC—adrenal gland cancer	0.000512	0.000764	CbGpPWpGaD
Droxidopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00051	0.000762	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000509	0.00076	CbGpPWpGaD
Droxidopa—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	0.000506	0.000755	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000498	0.000744	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GNRH1—adrenal gland cancer	0.000493	0.000735	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000492	0.000735	CbGpPWpGaD
Droxidopa—PAH—Metabolism—PTGS2—adrenal gland cancer	0.000492	0.000735	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000492	0.000735	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000486	0.000726	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—PRKACA—adrenal gland cancer	0.000484	0.000722	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000482	0.000719	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—POMC—adrenal gland cancer	0.000478	0.000714	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000476	0.000711	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000475	0.00071	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—RRM1—adrenal gland cancer	0.000475	0.000708	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—SDHD—adrenal gland cancer	0.000475	0.000708	CbGpPWpGaD
Droxidopa—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000472	0.000705	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	0.000471	0.000703	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000454	0.000678	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—CDC42—adrenal gland cancer	0.000453	0.000675	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SPRY2—adrenal gland cancer	0.000451	0.000673	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00045	0.000672	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00045	0.000672	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000449	0.00067	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—POMC—adrenal gland cancer	0.000447	0.000667	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000445	0.000664	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000444	0.000663	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000443	0.000661	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000439	0.000655	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TSHR—adrenal gland cancer	0.000439	0.000655	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—MED12—adrenal gland cancer	0.000436	0.00065	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000434	0.000648	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—GNAS—adrenal gland cancer	0.000432	0.000645	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00043	0.000642	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000424	0.000633	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00042	0.000627	CbGpPWpGaD
Droxidopa—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000419	0.000626	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000418	0.000624	CbGpPWpGaD
Droxidopa—PAH—Disease—EGFR—adrenal gland cancer	0.000417	0.000622	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	0.000415	0.00062	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000414	0.000617	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MEN1—adrenal gland cancer	0.000413	0.000616	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000412	0.000615	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000411	0.000613	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CDC42—adrenal gland cancer	0.00041	0.000613	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	0.000409	0.00061	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000409	0.00061	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000407	0.000607	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000403	0.000602	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000402	0.000599	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000402	0.000599	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	0.0004	0.000597	CbGpPWpGaD
Droxidopa—DDC—Metabolism—POMC—adrenal gland cancer	0.000399	0.000596	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	0.000396	0.000592	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF2—adrenal gland cancer	0.000396	0.00059	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000395	0.00059	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000394	0.000588	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000393	0.000587	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—GNAS—adrenal gland cancer	0.000392	0.000585	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	0.000391	0.000584	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	0.00039	0.000583	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000389	0.00058	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000385	0.000575	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF1R—adrenal gland cancer	0.000382	0.000571	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	0.000382	0.00057	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	0.00038	0.000567	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	0.000376	0.000561	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	0.000376	0.000561	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	0.000374	0.000558	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	0.000373	0.000556	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	0.00037	0.000553	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	0.000368	0.000549	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000367	0.000548	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000365	0.000545	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	0.000365	0.000544	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	0.000364	0.000544	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000363	0.000542	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	0.000359	0.000536	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—MED12—adrenal gland cancer	0.000354	0.000528	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000351	0.000524	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	0.000348	0.00052	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	0.000343	0.000511	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000341	0.000509	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000337	0.000504	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000334	0.000498	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000332	0.000496	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TERT—adrenal gland cancer	0.000329	0.000491	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000326	0.000487	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	0.000324	0.000483	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—POMC—adrenal gland cancer	0.000321	0.000479	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000319	0.000476	CbGpPWpGaD
Droxidopa—DDC—Metabolism—PTGS2—adrenal gland cancer	0.000318	0.000475	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	0.000318	0.000474	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PRKACA—adrenal gland cancer	0.000315	0.00047	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.00031	0.000463	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000309	0.000461	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000304	0.000454	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000301	0.000449	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000296	0.000442	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000292	0.000436	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	0.000291	0.000435	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000289	0.000432	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000287	0.000429	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—BAD—adrenal gland cancer	0.000286	0.000427	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000286	0.000427	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000285	0.000425	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000283	0.000422	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000281	0.000419	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	0.00027	0.000404	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	0.000267	0.000399	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	0.000266	0.000397	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	0.000266	0.000397	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	0.000265	0.000396	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—POMC—adrenal gland cancer	0.000264	0.000394	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	0.000263	0.000392	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	0.000262	0.00039	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—BRAF—adrenal gland cancer	0.000261	0.000389	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	0.000259	0.000387	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	0.000258	0.000385	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	0.000258	0.000385	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GNAS—adrenal gland cancer	0.000258	0.000385	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	0.000255	0.000381	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	0.000253	0.000377	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000253	0.000377	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	0.000249	0.000372	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	0.000246	0.000366	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	0.000244	0.000364	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	0.000242	0.000361	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	0.000241	0.00036	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	0.000238	0.000356	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000236	0.000353	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	0.000235	0.00035	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	0.000233	0.000347	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	0.000233	0.000347	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000232	0.000347	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	0.000231	0.000344	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	0.00023	0.000343	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	0.000228	0.00034	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000227	0.000339	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	0.000225	0.000336	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000225	0.000336	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000222	0.000331	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	0.000222	0.000331	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.00022	0.000328	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TP53—adrenal gland cancer	0.000217	0.000325	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	0.000217	0.000324	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000216	0.000322	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	0.000215	0.000322	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000215	0.00032	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	0.000214	0.00032	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	0.000214	0.000319	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	0.000212	0.000316	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	0.00021	0.000314	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GNAS—adrenal gland cancer	0.000209	0.000312	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	0.000207	0.000309	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	0.000205	0.000306	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TP53—adrenal gland cancer	0.000203	0.000303	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000199	0.000298	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	0.000197	0.000294	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	0.000195	0.000292	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	0.000194	0.000289	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	0.000191	0.000285	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	0.00019	0.000284	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000188	0.000281	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000188	0.000281	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	0.000187	0.000278	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000184	0.000274	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000183	0.000273	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	0.000181	0.00027	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	0.000178	0.000266	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000176	0.000263	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000175	0.000261	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—POMC—adrenal gland cancer	0.000173	0.000259	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	0.000172	0.000257	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000171	0.000255	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	0.00017	0.000254	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	0.00017	0.000253	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	0.000168	0.000251	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	0.000166	0.000248	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TP53—adrenal gland cancer	0.000165	0.000246	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	0.000165	0.000246	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	0.000158	0.000236	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	0.000157	0.000235	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	0.000157	0.000234	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	0.000155	0.000232	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	0.000155	0.000231	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	0.000155	0.000231	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	0.000153	0.000229	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	0.000153	0.000229	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	0.000151	0.000226	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	0.00015	0.000224	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EGFR—adrenal gland cancer	0.000149	0.000223	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000149	0.000222	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	0.000147	0.000219	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000147	0.000219	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	0.000145	0.000216	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	0.000143	0.000214	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	0.000143	0.000213	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	0.000141	0.00021	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—POMC—adrenal gland cancer	0.000141	0.00021	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	0.000139	0.000207	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	0.000138	0.000207	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	0.000138	0.000205	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	0.000137	0.000204	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	0.000128	0.000191	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	0.000127	0.000189	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TP53—adrenal gland cancer	0.000125	0.000187	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000125	0.000187	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000123	0.000183	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000121	0.000181	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	0.000118	0.000176	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	0.000116	0.000174	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000113	0.000168	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	0.000112	0.000168	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000112	0.000167	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000111	0.000165	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000109	0.000163	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000104	0.000154	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000102	0.000152	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	9.72e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	9.05e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	8.86e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	8.78e-05	0.000131	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	8.67e-05	0.000129	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	8.41e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	8.2e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	8.16e-05	0.000122	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	8.07e-05	0.00012	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	7.44e-05	0.000111	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	7.37e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	7.28e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	7.17e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	6.89e-05	0.000103	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	6.78e-05	0.000101	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	6.66e-05	9.94e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	6.02e-05	8.98e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	5.59e-05	8.35e-05	CbGpPWpGaD
